NSF-MR-Contrastmedia - Introduction
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Until recently it was believed that extracellular gadolinium based contrast agents (Gd-CA) were safe for both the kidneys and all other organs within the dose range up to 0.3 mmol/kg body weight. However, in 2006, it was demonstrated that some Gd-CA may trig the development of nephrogenic systemic fibrosis, a generalized fibrotic disorder, in renal failure patients. This sub-section of European Journal of Radiology covers the current knowledge about NSF from many aspects. The prevention of NSF must be given high priority, but it should not lead to a denial of a well-justified, enhanced MRI examination with a stable agent. (C) 2008 Elsevier Ireland Ltd. All rights reserved
Udgivelsesdato: 2008/5
Udgivelsesdato: 2008/5
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Journal of Radiography |
Vol/bind | 66 |
Udgave nummer | 2 |
Sider (fra-til) | 153-159 |
Antal sider | 6 |
ISSN | 1756-1175 |
Status | Udgivet - 2008 |
Bibliografisk note
Times Cited: 0Editorial MaterialEnglishThomsen, H. SCopenhagen Univ Hosp, Dept Diagnost Radiol 54E2, Herlev Ringvej 75, DK-2730 Herlev, DenmarkCited References Count: 20304WXELSEVIER IRELAND LTDELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELANDCLARE
ID: 13708761